Advertisement

Rheumatological Manifestations of Crohn’s Disease

  • Giovanni Minisola
  • Giuseppe Famularo
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

The correlation between inflammatory bowel disease (IBD) and articular involvement has long been well known, but a nosographic classification was proposed only in the early 1970s, when two clinical forms of chronic intestinal inflammation were identified: Crohn’s disease (CD) and ulcerative colitis (UC). Both conditions were considered to be responsible for the peculiar forms of arthritis seen in a subset of patients with seronegative spondyloarthritides (SnSp) (Fig. 18.1) [1]. Numerous clinical and experimental findings subsequently drew strong attention to the enormous relevance of the relationship between IBD and either axial or peripheral articular inflammations [2,3].
Fig. 18.1

Linical conditions belonging to the group of seronegative spondyloarthritides (SnSp). IBD. inflammatory bowel disease: SAPHO, synovitis, acne, pustulosis, hyperostosis, osteitis

Keywords

Inflammatory Bowel Disease Ankylose Spondylitis Sacroiliac Joint Joint Involvement Intestinal Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wright V, Moll JMH (eds) (1976) Seronegative polyarthritis. Holland Publishing Company, AmsterdamGoogle Scholar
  2. 2.
    Dekker-Sayes BJ, Meuwissen SG, Van Den Berg-Loonen EM et al (1978) Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis 37:33–35CrossRefGoogle Scholar
  3. 3.
    Rynes RI, Volastro PS, Bartholomew LE (1984) Exacerbation of B27 positive spondyloarthropathy by enteric infections. J Rheumatol 11:96–97PubMedGoogle Scholar
  4. 4.
    Ebringer A, Ghuloom M (1986) Ankylosing spondylitis, HLA-B27, and Klebsiella: cross reactivity and antibody studies. Ann Rheum Dis 45:703–704CrossRefPubMedGoogle Scholar
  5. 5.
    Mielants H, Veys EM, Cuvelier C et al (1987) Significance of gut inflammation in the seronegative spondyloarthropathies. Clin Exp Rheum 5 Suppl 1:S81–S87Google Scholar
  6. 6.
    Das KM (1999) Relationship of extraintestinal involvement in inflammatory bowel disease. Dig Dis Sci 44:1–13CrossRefPubMedGoogle Scholar
  7. 7.
    Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropaties in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391PubMedCrossRefGoogle Scholar
  8. 8.
    Repiso A, Alcántara M, Muñoz-Rosas C et al (2006) Extraintestinal manifestations of Crohn’s disease: prevalence and related factors. Rev Esp Enferm Dig 98:510–517PubMedGoogle Scholar
  9. 9.
    Ardizzone S, Sarzi Puttini P, Cassinotti A, Bianchi Porro G (2008) Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 40 Suppl 2:S253–S259CrossRefPubMedGoogle Scholar
  10. 10.
    Mader R, Segol O, Adawi M et al (2005) Arthritis or vasculitis as presenting symptoms of Crohn’s disease. Rheumatol Int 25:401–405CrossRefPubMedGoogle Scholar
  11. 11.
    Fornaciari G, Salvarani C, Beltrami M et al (2001) Musculoskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol 15:339–403Google Scholar
  12. 12.
    Steer S, Jones H, Hibbert J et al (2003) Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn-s disease. J Rheumatol 30:518–522PubMedGoogle Scholar
  13. 13.
    Farmer RG, Michener WM (1979) Prognosis of Crohn’s disease with onset in childhood or adolescence. Dig Dis Sci 24:752–757CrossRefPubMedGoogle Scholar
  14. 14.
    Hamilton JR, Bruce GA, Abdurrahman M, Gall DG (1979) Inflammatory bowel disease in children and adolescent. Adv Pediatr 26:311–41PubMedGoogle Scholar
  15. 15.
    Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis Clin N Am 29:513–530CrossRefGoogle Scholar
  16. 16.
    Sand born WJ, Stemson WF, Brinson J et al (2006) Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol 4:203–211CrossRefGoogle Scholar
  17. 17.
    Van den Bosch F, Kruithof E, De Vos M et al (2000) Crohn’s disease associated with spondyloarthropathy: effect of TNF-a blockade with infliximab on the articular symptoms. Lancet 356:1821–1822CrossRefPubMedGoogle Scholar
  18. 18.
    De Keyser F, Baeten D, Van den Bosch F et al (2003) Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulation. Rheum Dis Clin North Am 29:463–479CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2010

Authors and Affiliations

  • Giovanni Minisola
    • 1
  • Giuseppe Famularo
    • 2
  1. 1.Rheumatology UnitSan Camillo-Forlanini HospitalRomeItaly
  2. 2.Department of Internal MedicineSan Camillo-Forlanini HospitalRomeItaly

Personalised recommendations